Summit Therapeutics plc : Holding(s) in Company




19.10.16 13:05
dpa-AFX


|TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) | +------------------------------------------------------------------------------+


+----------------------------------------------+-------------------------------+

|1. Identity of the issuer or the underlying   |                               |
|issuer                                        |    Summit Therapeutics PLC    |
|of existing shares to which voting rights are |         Sedol BN40HZ0         |
|attached: (ii)                                |                               |
+----------------------------------------------+-------------------------------+ |2 Reason for the notification (please tick the appropriate box or boxes): | +------------------------------------------------------------------+-----------+
|An acquisition or disposal of voting rights                       |           |
+------------------------------------------------------------------+-----------+
|An acquisition or disposal of qualifying financial instruments    |           |
|which may result in the acquisition of shares already issued to   |           |
|which voting rights are attached                                  |           |
+------------------------------------------------------------------+-----------+
|An acquisition or disposal of instruments with similar economic   |           |
|effect to qualifying financial instruments                        |           |
+------------------------------------------------------------------+-----------+
|An event changing the breakdown of voting rights                  |     X     |
+------------------------------------------------------------------+-----------+
|Other (please specify):                                           |           |
+--------------------------------------+---------------------------+-----------+
|                                      |(1)Lansdowne Partners International    |
|3. Full name of person(s) subject to  |Limited                                |
|the                                   |                                       |
|notification obligation: (iii)        |(2)Lansdowne Partners Limited          |
|                                      |                                       |
|                                      |(3)Lansdowne Partners (UK) LLP         |
+--------------------------------------+---------------------------------------+
|                                      |HSBC Client Holdings Nominee (UK) Ltd, |
|4. Full name of shareholder(s)        |HSBC Bank Plc Lansdowne Markets        |
| (if different from 3.):iv            |                                       |
|                                      |(Registered Shareholders)              |
+--------------------------------------+---------------------------------------+
|5. Date of the transaction and date on|                                       |
|which the threshold is crossed or     |13/10/2016                             |
|reached: (v)                          |                                       |
+--------------------------------------+---------------------------------------+
|6. Date on which issuer notified:     |18/10/2016                             |
+--------------------------------------+---------------------------------------+
|7. Threshold(s) that is/are crossed or|18% (Voting rights attached to shares  |
|reached: (vi, vii)                    |only)                                  |
+--------------------------------------+---------------------------------------+



+------------------------------------------------------------------------------ -+ |8. Notified details: | +------------------------------------------------------------------------------ -+ |A: Voting rights attached to shares (viii, ix) | +------------+----------------------+------------------------------------------ -+

|Class/type  |Situation previous    |Resulting situation after the triggering  
|
|of          |to the triggering     |transaction                               
|
|shares      |transaction           |                                          
| | +----------+-----------+---------+-----------------+-------------- -+
|if possible |Number    |Number     |Number   |Number of voting |% of  voting  
|
|using       |of        |of         |of shares|rights           |rights (x)    
|
|the ISIN    |Shares    |Voting     +---------+------+----------+------+-------
-+
|CODE        |          |Rights     |Direct   |Direct|Indirect 
|Direct|Indirect|
|            |          |           |         |(xi)  |(xii)     |      |       
| +------------+----------+-----------+---------+------+----------+------+------- -+
|  Ordinary  |          |           |         |      |          |      |       
|
|   Shares   |11,077,170|11,077,170 |         |      |11,077,170|      |17.95% 
|
|            |          |           |         |      |          |      |       
|
|GB00BN40HZ01|          |           |         |      |          |      |       
| +------------+----------+-----------+---------+------+----------+------+------- -+


+------------------------------------------------------------------------------ -+ |B: Qualifying Financial Instruments | +------------------------------------------------------------------------------ -+ |Resulting situation after the triggering transaction | +--------------+----------+--------------------+------------------+------------ -+

|Type of       |Expiration|Exercise/           |Number of voting  |% of voting 
|
|financial     |date      |Conversion Period   |rights that may be|rights      
|
|instrument    |(xiii)    |(xiv)               |acquired if the   |            
|
|              |          |                    |instrument is     |            
|
|              |          |                    |exercised/        |            
|
|              |          |                    |converted.        |            
| +--------------+----------+--------------------+------------------+------------ -+
|   American   |          |                    |                  |            
|
|  Depositary  |   N/A    |        N/A         |    4,650,000     |    7.53%   
|
| Shares (ADS) |          |                    |                  |            
| +--------------+----------+--------------------+------------------+------------ -+


+------------------------------------------------------------------------------ -+ |C: Financial Instruments with similar economic effect to Qualifying Financial | |Instruments (xv, xvi) | +------------------------------------------------------------------------------ -+ |Resulting situation after the triggering transaction | +-------------+---------+----------+----------+------------------+------------- -+

|Type of      |Exercise |Expiration|Exercise/ |Number of voting  |% of voting  
|
|financial    |price    |date      |Conversion|rights instrument |rights (xix, 
|
|instrument   |         |(xvii)    |period    |refers to         |xx)          
|
|             |         |          |(xviii)   |                  |             
| +-------------+---------+----------+----------+------------------+-------+----- -+
|             |         |          |          |                  |Nominal|Delta
|
|             |         |          |          |                 
+-------+------+
|             |         |          |          |                  |       |     
| +-------------+---------+----------+----------+------------------+-------+----- -+


+------------------------------------------------------------------------------ -+ |Total (A+B+C) | +------------------------------------+----------------------------------------- -+ |Number of voting rights |Percentage of voting rights | +------------------------------------+----------------------------------------- -+ |15,727,170 |25.48% | +------------------------------------+----------------------------------------- -+



+------------------------------------------------------------------------------+ |9. Chain of controlled undertakings through which the voting rights and/or the| |financial instruments are effectively held, if applicable: (xxi) | +------------------------------------------------------------------------------+ |Lansdowne Partners International Limited is the parent undertaking of | |Lansdowne Partners Limited which is the First Corporate Member of Lansdowne | |Partners (UK) LLP | +------------------------------------------------------------------------------+


+------------------------------------------------------------------------------+ |Proxy Voting: | +---------------------------------------------+--------------------------------+

|10. Name of the proxy holder:                |                                |
+---------------------------------------------+--------------------------------+
|11. Number of voting rights proxy holder will|                                |
|cease                                        |                                |
|to hold:                                     |                                |
+---------------------------------------------+--------------------------------+
|12. Date on which proxy holder will cease to |                                |
|hold                                         |                                |
|voting rights:                               |                                |
+---------------------------------------------+--------------------------------+


+----------------------------+-------------------------------------------------+

|                            |                                                 |
|13. Additional information: |Based on total voting rights of 61,723,256       |
|                            |                                                 |
|                            |                                                 |
+----------------------------+-------------------------------------------------+
|14. Contact name:           |Ruari Paton                                      |
+----------------------------+-------------------------------------------------+
|15. Contact telephone       |+44 020 7290 5500                                |
|number:                     |                                                 |
+----------------------------+-------------------------------------------------+





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.


Source: Summit Therapeutics plc via GlobeNewswire



A0DKWDBN40HZ0R30


Copyright RTT News/dpa-AFX



MMMM





 
 
hier klicken zur Chartansicht

Aktuelle Kursinformationen mehr >
Kurs Vortag Veränderung Datum/Zeit
1,897 € 1,968 € -0,071 € -3,61% 05.12./21:21
 
ISIN WKN Jahreshoch Jahrestief
GB00BN40HZ01 A115K3 2,77 € 1,00 €
Werte im Artikel
35,50 plus
+0,31%
37,46 plus
+0,15%
1,90 minus
-3,61%
Handelsplatz Letzter Veränderung  Zeit
 
Tradegate (RT)
1,54 € 0,00%  28.04.16
Berlin 1,979 € +1,49%  08:08
Stuttgart 1,897 € -3,61%  16:13
  = Realtime
Aktien des Tages
  


Mit der Anmeldung für den Newsletter "Aktien des Tages" stimme ich dem gleichzeitigen Erhalt des "GeVestor täglich" unseres Partners GeVestor zu.


Mit der Anmeldung für den Newsletter "Aktien des Tages" stimme ich dem gleichzeitigen Erhalt des "Investors Daily" unseres Partners FID Verlag zu.

Meistgelesene Artikel
Aktuelle Diskussionen
Es ist noch kein Thema vorhanden.
RSS Feeds




Bitte warten...